This week, the Australian government approved the use of the Efferon device in the country. The authorization was issued to our partner, Medigroup, which has become the 14th international partner of our company, and certainly the most geographically distant.

Founded in 2004, Medigroup EBI has a strong track record in securing regulatory approval and reimbursement for niche medical technologies from around the world.

Efferon is a next-generation hemoadsorption cartridge designed to remove both endotoxins and cytokines from the bloodstream. It was approved in the EU for use in sepsis patients under the MDR regulation.